126 related articles for article (PubMed ID: 15042686)
21. Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan.
Lee KD; Chen SC; Chan CH; Lu CH; Chen CC; Lin JT; Chen MF; Huang SH; Yeh CM; Chen MC
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2647-55. PubMed ID: 18843006
[TBL] [Abstract][Full Text] [Related]
22. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
23. Ovarian cancer is a heterogeneous disease.
Wang V; Li C; Lin M; Welch W; Bell D; Wong YF; Berkowitz R; Mok SC; Bandera CA
Cancer Genet Cytogenet; 2005 Sep; 161(2):170-3. PubMed ID: 16102589
[TBL] [Abstract][Full Text] [Related]
24. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
25. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
26. Nonbreast second malignancies after treatment of primary breast cancer.
Yadav BS; Sharma SC; Patel FD; Ghoshal S; Kapoor R; Kumar R
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1489-92. PubMed ID: 18804919
[TBL] [Abstract][Full Text] [Related]
27. Familial clustering of ovarian and endometrial cancers.
Hemminki K; Granström C
Eur J Cancer; 2004 Jan; 40(1):90-5. PubMed ID: 14687794
[TBL] [Abstract][Full Text] [Related]
28. Epithelial ovarian cancer and low malignant potential (LMP) tumors associated with a lower incidence of second primary breast cancer.
Hunter MI; Ziogas A; Flores F; Brewster WR
Am J Clin Oncol; 2007 Feb; 30(1):1-7. PubMed ID: 17278887
[TBL] [Abstract][Full Text] [Related]
29. Familial association of histology specific breast cancers with cancers at other sites.
Lorenzo Bermejo J; Hemminki K
Int J Cancer; 2004 Apr; 109(3):430-5. PubMed ID: 14961583
[TBL] [Abstract][Full Text] [Related]
30. [Stage I ovarian carcinoma: two distinct malignancies?].
Deligdisch L
Bull Acad Natl Med; 2007 Nov; 191(8):1695-700; discussion 1700-1. PubMed ID: 18666467
[TBL] [Abstract][Full Text] [Related]
31. Borderline ovarian tumours in Vaud, Switzerland: incidence, survival and second neoplasms.
Levi F; La Vecchia C; Randimbison L; Te VC
Br J Cancer; 1999 Jan; 79(1):4-6. PubMed ID: 10408684
[TBL] [Abstract][Full Text] [Related]
32. Incidence and mortality in epithelial ovarian cancer by family history of any cancer.
Hemminki K; Sundquist J; Brandt A
Cancer; 2011 Sep; 117(17):3972-80. PubMed ID: 21365633
[TBL] [Abstract][Full Text] [Related]
33. Age specific and attributable risks of familial prostate carcinoma from the family-cancer database.
Hemminki K; Czene K
Cancer; 2002 Sep; 95(6):1346-53. PubMed ID: 12216104
[TBL] [Abstract][Full Text] [Related]
34. Ovarian cancer incidence in the United States, 1992-1999.
Quirk JT; Natarajan N
Gynecol Oncol; 2005 May; 97(2):519-23. PubMed ID: 15863154
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for ovarian cancer histotypes.
Chiaffarino F; Parazzini F; Bosetti C; Franceschi S; Talamini R; Canzonieri V; Montella M; Ramazzotti V; Franceschi S; La Vecchia C
Eur J Cancer; 2007 May; 43(7):1208-13. PubMed ID: 17376671
[TBL] [Abstract][Full Text] [Related]
36. Survival in ovarian cancer patients by histology and family history.
Ji J; Försti A; Sundquist J; Lenner P; Hemminki K
Acta Oncol; 2008; 47(6):1133-9. PubMed ID: 18607880
[TBL] [Abstract][Full Text] [Related]
37. Cervical, endometrial and ovarian cancers among immigrants in Sweden: importance of age at migration and duration of residence.
Beiki O; Allebeck P; Nordqvist T; Moradi T
Eur J Cancer; 2009 Jan; 45(1):107-18. PubMed ID: 18829301
[TBL] [Abstract][Full Text] [Related]
38. Familial risk of cancer shortly after diagnosis of the first familial tumor.
Bermejo JL; Hemminki K
J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
[TBL] [Abstract][Full Text] [Related]
39. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
Young RH
Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
[TBL] [Abstract][Full Text] [Related]
40. Other primary malignancies in patients with uterine corpus malignancy.
Delin JB; Miller DS; Coleman RL
Am J Obstet Gynecol; 2004 May; 190(5):1429-31. PubMed ID: 15167859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]